When the pandemic struck in 2019, there were more than 51 million Americans experiencing some type of mental illness.

We looked at three of the leading medications belonging to the Interleukin antagonists group used to treat this condition that specifically treat psoriasis: secukinumab, risankizumab, and ixekizumab.

Why is it so complicated? Why can’t kidney transplant patients find the right donors? Or get the life-saving medical procedures they need when they need it? Let’s find out.